Recent News

Vinorelbine Could Soon be Used to Treat Mesothelioma

June 25, 2021

Vinorelbine could be a useful second-line treatment for patients with relapsed mesothelioma. A phase II clinical trial examined vinorelbine to see how effective it is in patients who had their…

Pleural Effusion in Mesothelioma Patients May Affect Survival

June 18, 2021

Pleural effusion may affect mesothelioma survival. Pleural effusion is a buildup of fluid around the lungs that can be caused by multiple illnesses including heart failure, kidney and liver disease,…

A Study of SAR444245 Combined With Other Anticancer Therapies for the Treatment of Participants With Lung Cancer or Mesothelioma

June 11, 2021

Primary Outcome Measures Objective response rate (ORR) [ Time Frame: Baseline to the date of first documented progression or initiation of subsequent anticancer therapy or approximatively 9 months after the last participant receive…

Adjuvant Radiotherapy Does Not Improve Survival in Pleural Mesothelioma Patients

June 11, 2021

Adjuvant radiotherapy might not be the best treatment for mesothelioma sufferers because researchers at Duke and Stanford found that this therapy does not help patients live longer. The researchers analyzed…

Study of NGM707 as Monotherapy and in Combination With Pembrolizumab in Advanced or Metastatic Solid Tumor Malignancies

June 4, 2021

Primary Outcome Measures Number of Patients with Dose-limiting Toxicities [ Time Frame: Baseline up to 28 Days ] A DLT is defined as an AE that meets at least one of the criteria listed…

Doctors Should Use Pleurectomy Decortication Surgery Over Extrapleural Pneumonectomy Surgery

June 4, 2021

A study looking at many patients with pleural mesothelioma found that there is not enough of a survival advantage to support the use of extrapleural pneumonectomy surgery (EPP). The study…

Mesothelioma Patients with High Levels of the PD-L1 Protein Have Shorter Survival

May 28, 2021

Unfortunately for mesothelioma patients with high levels of the PD-L1 protein, they have a worse overall survival compared to patients who have lower levels. A European study looking at 200…

Tri-Modality Therapy Triples Survival Compared to Chemotherapy and Surgery Alone

May 21, 2021

A very aggressive mesothelioma treatment is proving to be more beneficial compared to just chemotherapy and surgery alone. The more aggressive therapy utilizes multiple techniques creating a more successful treatment…

Pleurectomy/Decortication Surgery Can Improve Quality of Life, Even in Patients with Declining Lung Function

May 14, 2021

Researchers at the Hyogo College of Medicine have found that pleurectomy/decortication surgery can improve quality of life in mesothelioma patients, even if they have declining lung function. The researchers looked…

A Phase I Study of IAG933 in Patients With Advanced Mesothelioma and Other Solid Tumors

May 7, 2021

Primary Outcome Measures Number of patients with adverse events and serious adverse events [ Time Frame: 3 years ] Safety and tolerability of IAG933 Incidence of dose limiting toxicities during the first treatment cycle…